Abeona Therapeutics Inc. (ABEO) stock
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.60+0.00 (0.00%)
Close on Nov 17, 2026Market cap $148.68MP/E –Yield –
Abeona Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Abeona Therapeutics's price to book ratio was 1.0× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 0.3× to 13.0×, with a median of 2.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.0× | −0.6 |
| 2025 | Dec 31, 2025 | 1.6× | −3.7 |
| 2024 | Dec 31, 2024 | 5.3× | −0.3 |
| 2023 | Dec 29, 2023 | 5.6× | +3.7 |
| 2022 | Dec 30, 2022 | 1.9× | +1.5 |
| 2021 | Dec 31, 2021 | 0.4× | −0.7 |
| 2020 | Dec 31, 2020 | 1.2× | −0.6 |
| 2019 | Dec 31, 2019 | 1.7× | −0.5 |
| 2018 | Dec 31, 2018 | 2.2× | −4.8 |
| 2017 | Dec 29, 2017 | 7.0× | +4.5 |
| 2016 | Dec 30, 2016 | 2.5× | – |
See a number that looks wrong?